New Bill Aims To Limit ‘Revolving Door’ Between FDA And Industry

By Jessica Karins / May 22, 2024 at 12:07 PM
High-level officials at FDA along with the Centers for Disease Control and Prevention (CDC) and the National Institute of Health (NIH) would be barred from working in regulated industry for eight years, in addition to other new ethical requirements aiming to limit the “revolving door” between companies and federal agencies, under recently introduced legislation. While sponsored by Republicans and aimed squarely at public health officials the GOP has targeted since the COVID-19 response, the bill could attract some support from...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.